CD38-directed Cytolytic Antibody drugs
5 medications in the FDA established pharmacologic class “CD38-directed Cytolytic Antibody”.
| Drug | Type | NDC products |
|---|---|---|
| Sarclisa isatuximab | Rx | 2 |
| Darzalex Daratumumab | Rx | 1 |
| Darzalex Faspro daratumumab and hyaluronidase-fihj (human recombinant) | Rx | 1 |
| Darzalex IV Daratumumab | Rx | 1 |
| Sarclisa Escena isatuximab-irfc | Rx | 1 |